New Agents Making a Positive Impact in the Treatment of Hepatocellular Carcinoma


Ghassan K Abou-Alfa, MD, medical oncologist at the Memorial Sloan Kettering Cancer Center (New York, NY), discusses a few of the newer agents available for the treatment of hepatocellular carcinoma, and how these agents have impacted practice.




Stay in the know.
OncNet Newsletter